Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
주식 순위 #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
주가
$0.00185055
시가총액
$48.29K
변동 (1일)
-3.55%
변동 (1년)
30.31%
국가
GB
거래 Nuformix plc (NFX)

카테고리

Nuformix plc (NFX)의 P/S 비율
September 2026 기준 P/S 비율 TTM: 0.00
Nuformix plc의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0.00입니다. 2024년 말 기준 P/S 비율은 0.00였습니다.
Nuformix plc의 P/S 비율 기록 (2014 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH